期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 31, 期 4, 页码 276-286出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2020.01.004
关键词
-
资金
- Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) [261168, 284771]
- Universidad Nacional Autonoma de Mexico grant UNAM-PAPIIT [IN209518]
The pituitary hormone prolactin (PRL) regulates a variety of functions beyond reproduction. The association between physiological (pregnancy) and pathological (prolactinoma) hyperprolactinemia and metabolic alterations led to the concept of this hormone being diabetogenic. However, large cohort clinical studies have recently shown that low circulating PRL levels are associated with metabolic disease and represent a risk factor for type 2 diabetes (T2D), whereas high PRL levels are beneficial. Moreover, PRL acts on the pancreas, liver, adipose tissue, and hypothalamus to maintain and promote metabolic homeostasis. By integrating basic and clinical evidence, we hypothesize that upregulation of PRL levels is a mechanism to maintain metabolic homeostasis and, thus, propose that the range of PRL levels considered physiological should be expanded to higher values.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据